Brødkrumme Forside Erhvervsaktiviteter Lundbeckfonden Ventures Portfolio Portefølje nyheder Del på Facebook Del på Twitter Del på LinkedIn Send link til siden via mail Udskriv siden Portefølje nyheder Oversigt over seneste pressemeddelelser om selskaberne. Disse er udsendt af porteføljeselskaberne. Henvendelser vedr. spørgsmål og kommentarer kan rettes til det enkelte selskab. Søgeord Bonesupport 9. december 2019 BONESUPPORTTM CERTiFy STUDY ON CERAMENT ® BONE VOID FILLER NOW PUBLISHED IN THE JOURNAL OF BONE AND JOINT SURGERY Veloxis 25. november 2019 Veloxis to Host Conference Call Following Asahi Kasei Group’s Announcement of a Recommended Conditional Voluntary Public Offer for Veloxis BONESUPPORT 13. november 2019 BONESUPPORT appoints Fergus MacLeod as General Manager and Executive Vice President Commercial Operations EUROW Sanifit 12. november 2019 Sanifit to host webcast: Phase 2b CaLIPSO trial of SNF472 Sanifit 12. november 2019 Positive data from Sanifit’s Phase 2b CaLIPSO trial of SNF472 published in Circulation Bonesupport 7. november 2019 BONESUPPORT HOLDING AB (publ) – Publishes Q3 2019 Interim report Acacia Pharma 31. oktober 2019 Issue of Equity on Exercise of Options/Vesting of Performance Share Awards Bonesupport 31. oktober 2019 Change in number of shares and votes in BONESUPPORT HOLDING AB (publ) Bonesupport 30. oktober 2019 BONESUPPORT HOLDING AB (publ) – Q3 2019 Interim Report – invitation to conference call and webcast Sanifit 30. oktober 2019 Sanifit announces that the Phase 2b CaLIPSO trial of SNF472 met its primary endpoint in slowing the progression of cardiovascular calcification in patients on hemodialysis Top line data to be presented at 2019 Scientific Sessions of American Heart Associa Acacia Pharma 22. oktober 2019 Issue of Equity on Exercise of Options/Vesting of Performance Share Awards Bonesupport 30. september 2019 Change in number of shares and votes in BONESUPPORT HOLDING AB (publ) Acacia Pharma 26. september 2019 Acacia Pharma Group PLC – Acacia Pharma Announces New BARHEMSYS® PDUFA Target Date of 26 February 2020 Sanifit 23. september 2019 Sanifit named as one of 2019’s “Fierce 15” biotechnology companies by FierceBiotech Bonesupport 19. september 2019 BONESUPPORT HOLDING AB presents health economic evidence Acacia Pharma 17. september 2019 Acacia Pharma Group plc – Issue of Equity on Exercise of Options/Vesting of Performance Share Awards Amplyx Pharmaceuticals 17. september 2019 Amplyx Pharmaceuticals Licenses Phase 2 Drug Candidate for BK Viral Disease in Transplant Patients Amplyx Pharmaceuticals 17. september 2019 Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia Amplyx Pharmaceuticals 10. september 2019 FDA Grants Fast Track Status to Amplyx Pharmaceuticals for IV and Oral Formulations of Fosmanogepix (APX001) for Seven Different Indications Acacia Pharma 5. september 2019 Acacia Pharma Group plc – Interim Results for the Six Months ended 30 June 2019 Bonesupport 2. september 2019 Change in number of shares and votes in BONESUPPORT HOLDING AB (publ) Acacia Pharma 16. august 2019 Acacia Pharma Group PLC – Acacia Pharma Group plc – Issue of Equity on Exercise of Options Acacia Pharma 12. august 2019 Acacia Pharma Group PLC – Acacia Pharma Group plc: Notice of Interim Results Bonesupport 25. juli 2019 BONESUPPORT HOLDING AB (publ) – Publishes Q2 2019 Interim report Veloxis 23. juli 2019 Veloxis Revises Outlook for 2019 Based on Strong Performance Acacia Pharma 18. juli 2019 Acacia Pharma Group PLC – Acacia Pharma Founder Dr. Julian Gilbert steps down – Michael Bolinder, Chief Commercial Officer, becomes CEO in Planned Succession Bonesupport 18. juli 2019 BONESUPPORT HOLDING AB (publ) – Q2 2019 Interim Report – invitation to conference call and webcast scPharmaceuticals 16. juli 2019 scPharmaceuticals Inc. Provides Regulatory Update on FUROSCIX® Acacia Pharma 12. juli 2019 Acacia Pharma Group PLC – Editorial on Positive Data for BARHEMSYS® Treatment of Post-Operative Nausea & Vomiting (PONV) Published in Anesthesia & Analgesia Acacia Pharma 8. juli 2019 Acacia Pharma Group PLC – Acacia Pharma Plans to Resubmit the BARHEMSYS® NDA in Q3 2019 Sideinddeling Første side « Første Forrige side ‹‹ … Side 3 Side 4 Nuværende side 5 Side 6 Side 7 … Næste side ›› Sidste side Sidste » Erhvervsaktiviteter Lundbeckfonden BioCapital Strategiske investeringer Invest
